Cargando…
Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches
BACKGROUND: Growing evidence suggests psilocybin, a naturally occurring psychedelic, is a safe and promising pharmacotherapy for treatment of mood and substance use disorders when administered as part of a structured intervention. In most trials to date, psilocybin dose has been administered on a we...
Autores principales: | Garcia-Romeu, Albert, Barrett, Frederick S, Carbonaro, Theresa M, Johnson, Matthew W, Griffiths, Roland R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056712/ https://www.ncbi.nlm.nih.gov/pubmed/33611977 http://dx.doi.org/10.1177/0269881121991822 |
Ejemplares similares
-
Emotions and brain function are altered up to one month after a single high dose of psilocybin
por: Barrett, Frederick S., et al.
Publicado: (2020) -
Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin
por: Schartner, Michael M., et al.
Publicado: (2017) -
Therapeutic use of psilocybin: Practical considerations for dosing and administration
por: MacCallum, Caroline A., et al.
Publicado: (2022) -
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial
por: Davis, Alan K., et al.
Publicado: (2020) -
Efficacy and safety of psilocybin-assisted treatment for major
depressive disorder: Prospective 12-month follow-up
por: Gukasyan, Natalie, et al.
Publicado: (2022)